Recent FDA approvals in the treatment of graft-versus-host disease
DJ Martini, YB Chen, Z DeFilipp - The oncologist, 2022 - academic.oup.com
Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic
cell transplantation (HCT) and is associated with significant morbidity and mortality. For …
cell transplantation (HCT) and is associated with significant morbidity and mortality. For …
[HTML][HTML] Toward a better understanding of the atypical features of chronic graft-versus-host disease: a report from the 2020 National Institutes of Health Consensus …
GDE Cuvelier, M Schoettler, NP Buxbaum… - … and cellular therapy, 2022 - Elsevier
Alloreactive and autoimmune responses after allogeneic hematopoietic cell transplantation
can occur in nonclassical chronic graft-versus-host disease (chronic GVHD) tissues and …
can occur in nonclassical chronic graft-versus-host disease (chronic GVHD) tissues and …
Three US Food and Drug Administration–approved therapies for chronic GVHD
R Zeiser, SJ Lee - Blood, The Journal of the American Society …, 2022 - ashpublications.org
Chronic graft-versus-host disease (cGVHD) is a major immunologic complication of
allogeneic hematopoietic cell transplantation. cGVHD involves multiple organs, reduces …
allogeneic hematopoietic cell transplantation. cGVHD involves multiple organs, reduces …
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review
N Sonneveld, JH Rayment, J Usemann… - European …, 2023 - Eur Respiratory Soc
Pulmonary chronic graft-versus-host disease (cGVHD) is a substantial cause of pulmonary
morbidity and mortality post-haematopoietic stem cell transplantation (HSCT). Current …
morbidity and mortality post-haematopoietic stem cell transplantation (HSCT). Current …
The novel role of lymphatic vessels in the pathogenesis of ocular diseases
T Clahsen, K Hadrian, M Notara, SL Schlereth… - Progress in Retinal and …, 2023 - Elsevier
Historically, the eye has been considered as an organ free of lymphatic vessels. In recent
years, however, it became evident, that lymphatic vessels or lymphatic-like vessels …
years, however, it became evident, that lymphatic vessels or lymphatic-like vessels …
[HTML][HTML] Recent advances in ocular graft-versus-host disease
X Cheng, R Huang, S Huang, W Fan, R Yuan… - Frontiers in …, 2023 - frontiersin.org
Ocular graft-versus-host-disease (GVHD) remains a significant clinical complication after
allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other …
allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other …
[HTML][HTML] Clinical significance of microRNAs in hematologic malignancies and hematopoietic stem cell transplantation
A Sevcikova, I Fridrichova, N Nikolaieva, L Kalinkova… - Cancers, 2023 - mdpi.com
Simple Summary Dysregulated microRNA (miRNA) expression has been described in the
initiation and progression of a wide spectrum of hematologic malignancies. Moreover …
initiation and progression of a wide spectrum of hematologic malignancies. Moreover …
Multicenter prospective validation study for international chronic ocular graft-versus-host disease consensus diagnostic criteria
Y Ogawa, R Dana, S Kim, S Jain, MI Rosenblatt… - The Ocular Surface, 2022 - Elsevier
Purpose To validate the international chronic ocular graft-versus-host disease (GVHD)
diagnostic criteria (ICCGVHD) compared to the National Institute of Health diagnostic criteria …
diagnostic criteria (ICCGVHD) compared to the National Institute of Health diagnostic criteria …
[PDF][PDF] Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death
BACKGROUND Chronic graft-versus-host disease (cGVHD) is a serious complication of
allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding …
allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding …
[HTML][HTML] Current definitions and clinical implications of biomarkers in graft-versus-host disease
Hematopoietic cell transplantation (HCT) is a potentially curative treatment for many
hematologic and nonhematologic disorders. Graft-versus-host-disease (GVHD) in its acute …
hematologic and nonhematologic disorders. Graft-versus-host-disease (GVHD) in its acute …